Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bacillus-Calmette-Guerin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00694798
What this trial is testing

Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder

Who this might be right for
Bladder Cancer
Cadila Pharnmaceuticals 22
Testing effectiveness (Phase 2)Looking for participantsNCT05710848
What this trial is testing

STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
SURGE Therapeutics 75
Post-approval studies (Phase 4)Enrolling By InvitationNCT07005726
What this trial is testing

BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in Africa

Who this might be right for
Infant MorbidityInfant MortalityNon-Specific Effects of Vaccines+1 more
Bandim Health Project 6,000
Early research (Phase 1)Study completedNCT02709278
What this trial is testing

Aerosol BCG Challenge Trial in Healthy UK Adults

Who this might be right for
Tuberculosis
University of Oxford 46
Not applicableStudy completedNCT03383211
What this trial is testing

Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers

Who this might be right for
HIV InfectionsNeonatal InfectionLTBI - Latent Tuberculosis Infection+1 more
George Washington University 125
Large-scale testing (Phase 3)Ended earlyNCT04453293
What this trial is testing

Immunization With BCG Vaccine to Prevent Tuberculosis Infection

Who this might be right for
Tuberculosis Infection
Henry M. Jackson Foundation for the Advancement of Military Medicine 16
Large-scale testing (Phase 3)Study completedNCT00406068
What this trial is testing

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Neoplasms
Bioniche Life Sciences Inc. 129
Early research (Phase 1)Active Not RecruitingNCT05843448
What this trial is testing

IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer

Who this might be right for
High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more
University of California, Davis 6
Not applicableNot Yet RecruitingNCT07724886
What this trial is testing

Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC

Who this might be right for
Bladder Cancer
Chinese University of Hong Kong 732
Not applicableStudy completedNCT02259608
What this trial is testing

Γ-irradiated BCG to Train Innate Immunity

Who this might be right for
Innate Immune Response
Radboud University Medical Center 15
Early research (Phase 1)Active Not RecruitingNCT05768347
What this trial is testing

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

Who this might be right for
Urothelial CarcinomaNon-Invasive Bladder Urothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 9
Testing effectiveness (Phase 2)Study completedNCT05004038
What this trial is testing

BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection:

Who this might be right for
HIV-1-infection
University of Zurich 60
Testing effectiveness (Phase 2)Study completedNCT02712424
What this trial is testing

DAR-901 TB Booster Vaccine to Prevent TB in Adolescents

Who this might be right for
Tuberculosis
Dartmouth-Hitchcock Medical Center 625
Large-scale testing (Phase 3)UnknownNCT00052156
What this trial is testing

Vaccine Therapy for Patients With Stage IV Melanoma

Who this might be right for
Malignant Melanoma
CancerVax Corporation 670
Testing effectiveness (Phase 2)Active Not RecruitingNCT04386746
What this trial is testing

Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer

Who this might be right for
Urothelial Carcinoma BladderBladder Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Large-scale testing (Phase 3)UnknownNCT03664869
What this trial is testing

Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Turku University Hospital 300
Early research (Phase 1)Study completedNCT01378312
What this trial is testing

Evaluate Safety and Immunogenicity of AERAS-402

Who this might be right for
Tuberculosis
Aeras 12
Early research (Phase 1)UnknownNCT03806699
What this trial is testing

Phase 1 Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Adolescent

Who this might be right for
Tuberculosis
Quratis Inc. 36
Early research (Phase 1)Study completedNCT05592223
What this trial is testing

Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines

Who this might be right for
Tuberculosis
Fred Hutchinson Cancer Center 20
Not applicableStudy completedNCT04891380
What this trial is testing

BCG Biosensor and Non- and Invasive Monitoring During Emergency Medicine Cases, a Prospective Feasibility Study

Who this might be right for
Cardiac Arrest, Out-Of-HospitalHypotension and Shock
Oslo University Hospital 183
Next Page